Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dystrophin gene exon 44 pre-mRNA refers specifically to the precursor mRNA region encompassing exon 44 within the *DMD* transcript. This region is crucial for therapies aiming at restoring partial function in Duchenne muscular dystrophy by inducing targeted skipping during RNA processing—thereby enabling synthesis of a semi-functional form of dystrophin protein even when certain mutations are present.
Antisense oligonucleotides induce exon skipping during pre-mRNA splicing, leading to production of truncated dystrophin protein.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dystrophin Gene Exon 44 pre-mRNA (DMD exon 44 pre-mRNA).